Pfizer awarded grant to evaluate vaccine to protect newborns against group B Streptococcus infection

www.worldpharmanews.com Review:

Breaking World Pharma News - World Pharma News - one of the world's leading web-based pharmaceutical news publications - is committed to providing and disseminating the most prominent pharmaceutical news and achievements

http://www.worldpharmanews.com/business-and-industry Business & Industry News Channel - Business & Industry News Channel: Clinical Trials, Product, Corporate, Financial, Research, Development, Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi, Sankyo, Eli Lilly and Company, Genzyme, GlaxoSmithKline, Johnson & Johnson, Lundbeck, Merck, Merck KGaA, Novartis, Novo Nordisk, Nycomed, Pfizer, Roche, Sanofi, Shire, Takeda, UCB, ...

http://www.worldpharmanews.com/research-and-development Research & Development News Channel - Research and Development News RSS Channel Subscribe to Research and Development News by Email

http://www.worldpharmanews.com/events Conferences & Events News Channel - Pharmaceutical conferences, workshops, meetings, exhibitions, congress, meeting, convention, seminar, colloquium, symposium, forum, convocation, and other pharma events.

http://www.worldpharmanews.com/regulatory Regulatory Affairs News Channel - The U. S. Food and Drug Administration today announced that it has awarded 21 new clinical trial research grants totaling more than $23 million over the next four years

http://www.worldpharmanews.com/bayer/3676-bayer-shows-strong-performance Bayer shows strong performance - The Bayer Group remained on a path of growth in the third quarter of 2016 and took a major strategic step forward with the agreed acquisition of Monsanto.

http://www.worldpharmanews.com/amgen/3675-amgen-builds-its-digital-health-capabilities-through-investment-in-leading-digital-health-incubator Amgen builds its digital health capabilities through investment in leading digital health incubator - Amgen (Europe) GmbH, an affiliate of Amgen Inc. (NASDAQ:AMGN) (collectively, "Amgen") today announced an investment in eHealth Ventures, an Israel-based digital health incubator. The investment reflects Amgen's commitment to serving patients by driving innovation and sustainable healthcare through technology discovery, and recognizes the importance of Israel as a source of innovation in eHealth and digital technologies.

http://www.worldpharmanews.com/novartis Novartis - Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis is the only global company with leading positions in these areas. In 2014, the Group achieved net sales of USD 58.0 billion, while R&D throughout the Group amounted to approximately USD 9.9 billion (USD 9.6 billion excluding impairment and amortization charges).

http://www.worldpharmanews.com/novartis/3674-novartis-delivered-solid-third-quarter Novartis delivered solid third quarter - Net sales were USD 12.1 billion in the third quarter, as volume growth of 5 percentage points was more than offset by the negative impact of generic competition and pricing.

http://www.worldpharmanews.com/merckgroup Merck Group - Merck is a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials. The company has six businesses - Merck Serono, Consumer Health, Allergopharma, Biosimilars, Merck Millipore and Performance Materials - and generated sales of € 11.3 billion in 2014. Around 39,000 Merck employees work in 66 countries to improve the quality of life for patients, to foster the success of customers and to help meet global challenges. Merck is the world's oldest pharmaceutical and chemical company - since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70% interest, the founding family remains the majority owner of the company to this day. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are Canada and the United States, where the company operates as EMD Serono, EMD Millipore and EMD Performance Materials.

http://www.worldpharmanews.com/merckgroup/3673-get-your-startup-to-the-next-level Get your startup to the next level - The Merck Accelerator is looking for startups with the potential to reshape entire industries and make people's lives richer. The focus is on startups in the fields of healthcare, life science and performance materials - with a digital perspective. Do you have plans to internationalize your business? Are you ready to get your start-up to the next level?

http://www.worldpharmanews.com/roche/3672-roche-delivers-good-sales-growth-in-the-first-nine-months-of-2016 Roche delivers good sales growth in the first nine months of 2016 - Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced that Group sales increased 4% to CHF 37.5 billion. Sales in the Pharmaceuticals Division were up 4% to CHF 29.1 billion, driven by demand for breast cancer medicines Perjeta and Herceptin as well as for Actemra/RoActemra for rheumatoid arthritis.

http://www.worldpharmanews.com/research Research - Over the past few decades, many bacteria have become resistant to existing antibiotics, and few new drugs have emerged. A recent study from a U. K. commission on

http://www.worldpharmanews.com/research/3671-new-compound-shows-promise-in-treating-multiple-human-cancers New compound shows promise in treating multiple human cancers - A new compound, discovered jointly by international pharmaceutical company Servier, headquartered in France, and Vernalis (R&D), a company based in the UK, has been shown by researchers at the Walter and Eliza Hall Institute and Servier to block a protein that is essential for the sustained growth of up to a quarter of all cancers.

http://www.worldpharmanews.com/development Development - Researchers at the University of Liverpool have developed a new international guideline to help standardise how results from clinical trial studies are reported. Use of

http://www.worldpharmanews.com/development/3670-reshaping-the-future-of-global-clinical-trials-practice Reshaping the future of global clinical trials practice - Researchers at the University of Liverpool have developed a new international guideline to help standardise how results from clinical trial studies are reported. Use of the COS-STAR guideline, which is published in PLOS Medicine, could increase the efficiency and value of clinical research across the globe.

http://www.worldpharmanews.com/pfizer Pfizer - At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.

http://www.worldpharmanews.com/pfizer/3669-pfizer-awarded-grant-to-evaluate-vaccine-to-protect-newborns-against-group-b-streptococcus-infection Pfizer awarded grant to evaluate vaccine to protect newborns against group B Streptococcus infection - Pfizer Inc. (NYSE:PFE) today announced an award of a grant from the Bill & Melinda Gates Foundation to conduct a Phase 1/2 clinical trial of Pfizer's vaccine candidate against group B Streptococcus(group B strep or GBS) infection, a leading cause of neonatal sepsis, a serious life-threatening blood infection.

Country: 82.165.156.109, Europe, DE

City: 9.491 , Germany

M. Zinn - Software works perfectly, does what is is supposed to do.

Theer is no better backup software on the market and for the price. It installed with no problems on my XP and Vista machines. I use it to clone my hard drives but it does much more. I recently used it to clone my laptop drive, then upgraded the drive to a larger one and put the cloned image onto the new drive. Worked perfectly. Have had absolutely no problems since installed two months ago. Highly recommended.

RObB,Z-Hills, FL - GREAT to bypass filing keurig K cups!

I use it with my keurig simply because I didn't enjoy waiting long periods of time waiting for heated water to make it through the espresso grind and into my cup. I add 3 levels of extra fine ground into the primula and press the large sized cup button 2 to fill up my mug. I wash it over the sink and it's ready to use it again. It spills over periodically since the sides of the primula are not really high enough but could be since the keurig has a higher reach.

Treegirl - Amazing!

I started this product a month ago. Not only has my hair grown a good inch (even with two trims!) but it has helped my energy level! I feel great the days I take it. The taste is a little too medicinal for me so I take it with something to drink but I love this product!

Seattleite - Product is not as depicted - what I got was like opaque hand soap that didn't dissolve well

What I received was labeled "baby shampoo and wash" but it certainly wasn't the product shown here. What I expected was the same clear yellow liquid as their regular wash, just minus the fragrance. That's what it looks like in this picture. What I got instead was something more pearly/opaque like a hand soap. When I put the regular (scented) product in bathwater, it disperses easily and makes great bubbles. When I put the weirdly formulated "fragrance free" product in the water, it sticks together in rope-y blobs and just sort of sits on the bottom of the tub like sediment - it doesn't dissolve well at all unless I really lather it up. Very disappointed in this!